Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles
 

Open Access

Original Research

Med Arch. 2013; 67(6): 431-434


Features of Postmenopausal Uterine Haemorrhage

Sebija Izetbegovic, Goran Stojkanovic, Nihad Ribic, Eldar Mehmedbasic.

Cited by (2)

Abstract
Introduction: Postmenopausal uterine bleeding is a „cancer until proven otherwise“. Endometrial cancer is a typical disease among postmenopause woman, because every bleeding in this age etiology associated with endometrial cancer (10-30%). The lifespan of women today has been extended and post menopause today last one third of a woman’s life. Early diagnosis of endometrial cancer has a very high cure rate. Screening for this cancer has limits in practice and is necessary given the definition of high-risk groups would be subject to primary and secondary prevention. Goal: Primary to evaluate the leading causes of postmenopausal uterine bleeding among patients at risk for endometrial cancer (diabetes, obesity, nulliparity, late menopause (after 55 years) and compared them with the causes of postmenopausal uterine bleeding patients without this risk. Material and methods: A retrospective, descriptive study with a targeted sample of 50 consecutive patients who had registered postmenopausal uterine bleeding in high-risk groups (cohorts) and the same number of patients with postmenopausal uterine bleeding that does not belong to the risk group (control group). Each patient underwent clinical examination, then fractionated curettements and its histopathological verification and assessment of treated clinical stage of disease with PH analysis of the resected specimens. Results: The patients of the studied risk group were significantly affected by endometrial cancer compared with the control group (RR=2.45, 95% CI 1.2 4.6, p=0.005). Endocervical pathology did not differ between groups. Clinical forms of bleeding: for those that are profuse bleeding cancer was present in 54.6% of cases. With intermittent bleeding cancer is verified in the 33.3% of patients. Risk patient groups with cancer frequently suffer from clinically more advanced stages of histologically aggressive endometrial cancer (serous adenocarcinoma–type II, low differentiated cancer).

Key words: postmenopausal bleeding, endometrial cancer, risk factors, clinical forms of bleeding.



Similar Articles

extract promotes M2 polarization and reduces oligomeric amyloid-β-induced inflammatory reactions in microglial cells.
Sun ZQ, Liu JF, Luo W, Wong CH, So KF, Hu Y, Chiu K
Neural regeneration research. 2022; 17(1): 203-209

Brain insulin resistance: an early risk factor for Alzheimer's disease development in Down syndrome.
Barone E
Neural regeneration research. 2022; 17(2): 333-335

Central nervous system stimulation therapies in phantom limb pain: a systematic review of clinical trials.
Garcia-Pallero MÁ, Cardona D, Rueda-Ruzafa L, Rodriguez-Arrastia M, Roman P
Neural regeneration research. 2022; 17(1): 59-64

New sequential algorithm using Mac-2 binding protein glycosylation isomer to detect advanced carotid artery atherosclerosis.
Park H, Jun DW, Park HK, Park KY, Hwang HS
Annals of translational medicine. 2021; 9(7): 566

Circadian factors in comorbid insomnia and sleep apnea (COMISA).
Sweetman A, Reynolds A, Lack LC
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep M. 2021; ():


Full-text options


Add your Article(s) to Indexes
• citeindex.org






ScopeMed.com
CiteIndex.org
CancerLine
FoodsLine
PhytoMedline
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.